Cargando…
Novel approach for low‐dose pulmonary delivery of hydroxychloroquine in COVID‐19
Autores principales: | Fassihi, Safa C., Nabar, Neel R., Fassihi, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323163/ https://www.ncbi.nlm.nih.gov/pubmed/32562278 http://dx.doi.org/10.1111/bph.15167 |
Ejemplares similares
-
Databases for the targeted COVID‐19 therapeutics
por: Wang, Yunxia, et al.
Publicado: (2020) -
Lung tissue distribution of drugs as a key factor for COVID‐19 treatment
por: Wang, Yan, et al.
Publicado: (2020) -
The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
por: Sadasivam, Balakrishnan, et al.
Publicado: (2020) -
How Ho Chi Minh City adapted its care pathway to manage the first large-scale community transmission of COVID-19
por: Khue, Luong Ngoc, et al.
Publicado: (2023) -
Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality
por: De Schryver, Nicolas, et al.
Publicado: (2021)